These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6320441

  • 1. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J, Durocher AM, Lagrange M.
    Sem Hop; 1984 Jan 26; 60(3):169-74. PubMed ID: 6320441
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E, Di Lorenzo L, De Pergola G.
    G Clin Med; 1980 Aug 26; 61(8):628-42. PubMed ID: 7004986
    [No Abstract] [Full Text] [Related]

  • 3. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders.
    Jansen W, O'Connolly M, Lehmann E, Mayer M.
    Pharmacopsychiatry; 1986 Sep 26; 19(5):389-94. PubMed ID: 3534902
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H.
    Schweiz Rundsch Med Prax; 1979 Jul 31; 68(31):1005-11. PubMed ID: 379854
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of cerebrovascular insufficiency. A double blind trial of Cetal retard against cinnarizine (author's transl)].
    Bartels H.
    MMW Munch Med Wochenschr; 1977 Oct 28; 119(43):1407-10. PubMed ID: 412079
    [Abstract] [Full Text] [Related]

  • 6. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P.
    Brux Med; 1979 May 28; 59(5):279-85. PubMed ID: 380784
    [No Abstract] [Full Text] [Related]

  • 7. [A special flicker fusion frequency method for detection of the effects of gerontopharmaceuticals exemplified by the L-eburnamonine study].
    Plörer S, Gerstenbrand F, Lehmann HE, Saltuari L, Stralkowski E.
    Psychiatr Neurol Med Psychol (Leipz); 1985 Nov 28; 37(11):635-42. PubMed ID: 4089045
    [Abstract] [Full Text] [Related]

  • 8. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G, Nappi G, Bono G.
    Minerva Med; 1974 May 26; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
    Riccardi T, Passeri F, Locatelli F.
    Minerva Med; 1978 Sep 15; 69(42):2873-8. PubMed ID: 358021
    [Abstract] [Full Text] [Related]

  • 11. Open-labeled phase III clinical trials with vinpocetine in Japan.
    Ebi O.
    Ther Hung; 1985 Sep 15; 33(1):41-9. PubMed ID: 3915913
    [No Abstract] [Full Text] [Related]

  • 12. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
    Dekoninck WJ, Jocquet P, Jacquy J, Henriet M.
    Arzneimittelforschung; 1978 Sep 15; 28(9):1654-7. PubMed ID: 383107
    [Abstract] [Full Text] [Related]

  • 13. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N, Kusunoki T, Matsumoto S.
    Ther Hung; 1985 Sep 15; 33(1):13-21. PubMed ID: 3841996
    [No Abstract] [Full Text] [Related]

  • 14. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
    Mazzola C, Della Torre F, Izzo M, Colombo Pirola L.
    Clin Ter; 1979 Dec 15; 91(5):485-503. PubMed ID: 397034
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.
    Balestreri R, Fontana L, Astengo F.
    J Am Geriatr Soc; 1987 May 15; 35(5):425-30. PubMed ID: 3553281
    [Abstract] [Full Text] [Related]

  • 16. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK, Blechacz W.
    Arzneimittelforschung; 1977 May 15; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract] [Full Text] [Related]

  • 17. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H.
    Med Klin; 1979 Oct 24; Suppl():48-50. PubMed ID: 542168
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P.
    Arzneimittelforschung; 1978 Oct 24; 28(11):2165-8. PubMed ID: 582924
    [Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
    Marolda M, Fragassi N, Buscaino GA.
    Eur Neurol; 1978 Oct 24; 17 Suppl 1():159-66. PubMed ID: 381006
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV, Chukhrova VA, Solov'ev OU, Nepesov RR.
    Klin Med (Mosk); 1997 Oct 24; 75(11):51-3. PubMed ID: 9490359
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.